Lv11
10 积分 2023-02-24 加入
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
3小时前
待确认
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study
19天前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
1个月前
已完结
Clinical characteristics and HLA associations of azithromycin‐induced liver injury
1个月前
已完结
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
4个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
5个月前
已完结
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Upregulation of CD47
7个月前
已完结
皖公网安备34019202002308
